Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CLINICAL TRIAL DESIGN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 31 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Morganroth, J
      Focus on issues in measuring and interpreting changes in the QTc interval duration

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    2. Kaemmerer, WF; Rose, MS; Mehra, R
      Distribution of patients' paroxysmal atrial tachyarrhythmia episodes: Implications for detection of treatment efficacy

      JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
    3. Stallard, N; Whitehead, J; Todd, S; Whitehead, A
      Stopping rules for phase II studies

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    4. Phillips, CV
      The economics of 'more research is needed'

      INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
    5. MacArthur, RD; Chen, L; Mayers, DL; Besch, CL; Novak, R; van den Berg-Wolf, M; Yurik, T; Peng, G; Schmetter, B; Brizz, B; Abrams, D
      The rationale and design of the CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) trial

      CONTROLLED CLINICAL TRIALS
    6. Dowlati, A; Crosby, L; Remick, SC; Makkar, V; Levitan, N
      Paclitaxel added to the cisplatin/etoposide regimen in extensive-stage small cell lung cancer - the use of complete response rate as the primary endpoint in phase II trials

      LUNG CANCER
    7. Thall, PF; Sung, HG; Choudhury, A
      Dose-finding based on feasibility and toxicity in T-cell infusion trials

      BIOMETRICS
    8. Claxton, K; Lacey, LF; Walker, SG
      Selecting treatments: a decision theoretic approach

      JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY
    9. Kaptchuk, TJ; Goldman, P; Stone, DA; Stason, WB
      Do medical devices have enhanced placebo effects?

      JOURNAL OF CLINICAL EPIDEMIOLOGY
    10. Stadler, WM; Ratain, MJ
      Development of target-based antineoplastic agents

      INVESTIGATIONAL NEW DRUGS
    11. Machado, SG; Murray, GD; Teasdale, GM
      Evaluation of designs for clinical trials of neuroprotective agents in head injury

      JOURNAL OF NEUROTRAUMA
    12. Cronin, KA; Freedman, LS; Lieberman, R; Weiss, HL; Beenken, SW; Kelloff, GJ
      Bayesian monitoring of Phase II trials in cancer chemoprevention

      JOURNAL OF CLINICAL EPIDEMIOLOGY
    13. Heasman, PA; McCraken, GI
      Powered toothbrushes: a review of clinical trials

      JOURNAL OF CLINICAL PERIODONTOLOGY
    14. Morris, GF; Bullock, R; Marshall, SB; Marmarou, A; Maas, A; Marshall, LF
      Failure of the competitive N-methyl-D-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: results of two Phase III clinical trials

      JOURNAL OF NEUROSURGERY
    15. Stallard, N; Thall, PF; Whitehead, J
      Decision theoretic designs for phase II clinical trials with multiple outcomes

      BIOMETRICS
    16. RICHARDSON D; LEURGANS S
      SAMPLE-SIZE JUSTIFICATION IN PHASE III IV CLINICAL-TRIALS/

      Neuroepidemiology
    17. AZEN SP; PETERS RK; BERKOWITZ K; KJOS S; XIANG A; BUCHANAN TA
      TRIPOD (TROGLITAZONE IN THE PREVENTION OF DIABETES) - A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF TROGLITAZONE IN WOMEN WITH PRIOR GESTATIONAL DIABETES-MELLITUS

      Controlled clinical trials
    18. BEYDOUN A; FISCHER J; LABAR DR; HARDEN C; CANTRELL D; UTHMAN BM; SACKELLARES JC; ABOUKHALIL B; RAMSAY RE; HAYES A; GREINER M; GAROFALO E; PIERCE M
      GABAPENTIN MONOTHERAPY .2. A 26-WEEK, DOUBLE-BLIND, DOSE-CONTROLLED, MULTICENTER STUDY OF CONVERSION FROM POLYTHERAPY IN OUTPATIENTS WITH REFRACTORY COMPLEX PARTIAL OR SECONDARILY GENERALIZED SEIZURES

      Neurology
    19. BIALER M; JOHANNESSEN SI; KUPFERBERG HJ; LEVY RH; LOISEAU P; PERUCCA E
      PROGRESS REPORT ON NEW ANTIEPILEPTIC DRUGS - A SUMMARY OF THE 3RD EILAT CONFERENCE

      Epilepsy research
    20. SHERIDAN PH; JACOBS MP
      THE DEVELOPMENT OF ANTIEPILEPTIC DRUGS FOR CHILDREN - REPORT FROM THENIH WORKSHOP, BETHESDA, MARYLAND, FEBRUARY 17-18, 1994

      Epilepsy research
    21. SCHULMAN KA; GLICK H; BUXTON M; SCULPHER M; BACKHOUSE M; BELL L; EISENBERG JM
      THE ECONOMIC-EVALUATION OF THE FIRST STUDY - DESIGN OF A PROSPECTIVE ANALYSIS ALONGSIDE A MULTINATIONAL PHASE-III CLINICAL-TRIAL

      Controlled clinical trials
    22. WHITLEY RJ; GNANN JW; WEISS HL; SOONG SJ
      UNIQUE CLINICAL-TRIAL DESIGN - COMBINATION ACYCLOVIR PLUS PREDNISONE THERAPY OF LOCALIZED ZOSTER IN THE NORMAL HOST

      Antiviral research
    23. REICHELDERFER PS; COOMBS RW
      CARTESIAN COORDINATE ANALYSIS OF VIRAL BURDEN AND CD4- IMPLICATIONS FOR CLINICAL-TRIAL DESIGN AND ANALYSIS( CELL COUNT IN HIV DISEASE )

      Antiviral research
    24. SABERS A; GRAM L
      DRUG-TREATMENT OF EPILEPSY IN THE 1990S - ACHIEVEMENTS AND NEW DEVELOPMENTS

      Drugs
    25. ROTHENBERG ML; ABBRUZZESE JL; MOORE M; PORTENOY RK; ROBERTSON JM; WANEBO HJ
      A RATIONALE FOR EXPANDING THE END-POINTS FOR CLINICAL-TRIALS IN ADVANCED PANCREATIC-CARCINOMA

      Cancer
    26. STABLES JP; BIALER M; JOHANNESSEN SI; KUPFERBERG HJ; LEVY RH; LOISEAU P; PERUCCA E
      PROGRESS REPORT ON NEW ANTIEPILEPTIC DRUGS A SUMMARY OF THE 2ND EILAT-CONFERENCE

      Epilepsy research
    27. HOLFORD NHG; WILLIAMS PEO; MUIRHEAD GJ; MITCHELL A; YORK A
      POPULATION PHARMACODYNAMICS OF ROMAZARIT

      British journal of clinical pharmacology
    28. THALL PF; SIMON R
      A BAYESIAN-APPROACH TO ESTABLISHING SAMPLE-SIZE AND MONITORING CRITERIA FOR PHASE-II CLINICAL-TRIALS

      Controlled clinical trials
    29. BROWN RH; LYNCH M; LEEF D; GUNSBY J; LOBER K; MOORE K; STEPKA C; VELATHOMAS A; GAASTERLAND DE; COYLE E; HUNDLEY M; ASHBURN F; VAYER L; MICHELITSCH K; LAUBER S; BURT E; RAE A; WEBER PA; DERICK R; MCKINNEY K; MOORE D; BAKER ND; KAPETANSKY F; LEHMAN D; GLOECKNER B; SHARF LJ; ROMANS B; SATTERWHITE Y; SIMMONS L; HARBIN TS; OZMENT RR; WRIGHT J; BUTLER L; LASALLE J; PERRY M; NUMMERDOR D; WILLE L; ECKEL A; SESSION C; MARTIN A; CYRLIN MN; FAZIO R; WILENSKY JT; LINDENMUTH K; NAIL CA; RATHBONE D; GATES V; TADELMAN M; SONTY S; HOPKINS G; HIGGINBOTHAM EJ; SCHOLES G; UVA R; PAPPAS L; FROHLICHSTEIN D; FIENE J; BERGSTROM TJ; LICHTER PR; STANDARDI C; ZIEHMSCOTT J; PAPIERNIAKDUBIEL R; POLLACKRUNDLE C; SKUTA GL; BEESON C; CREW RP; KRUSEKE L; MICHAEL B; DEDERIAN J; WICKER D; AARON D; BIRK J; VANHECK T; ALLEN RC; NEWMAN SA; NORLUND JR; FENDLEY CK; BERGHUIS C; CHISHOLM J; EVANS C; MURPHY E; SCHOTT LJ; FORNILI R; SCHWARTZ AL; WEISS H; WEHRLY S; PAPPAS S; ODEA M; BOECKL A; LOPEZ P; CARMODY K; MERCER R; MONKS V; VAWTER K; WITOL CV; CIRONE M; GURLEY J; REED C; BROWNING J; HARRIS E; KATZ LJ; SPAETH GL; WILSON RP; SAMUEL F; BLOCK A; KAO S; BEKERSHOFF CC; CAPRIOLI J; MILLER E; ROCHE M; GROTTOLE G; LEONE A; TRESSLER C; EDERER F; SULLIVAN EK; WAGNER EL; ENTLER G; BRADFORD M; TOMLIN KL; STINE E; LINDBLAD AS; KNOKE JD; DENEKAS M; SMITH C; VOSS T; MOWERY RL; LYNCH G; GOFF F; FURBERG CD; CONNETT JE; DAVIS MD; DUEKER DK; GREEN SB; HAMILTON MP; SCHNEIDERMAN MA; KASSOFF A; MORRIS M; PALMBERG PF
      THE ADVANCED GLAUCOMA INTERVENTION STUDY (AGIS) .1. STUDY DESIGN AND METHODS AND BASE-LINE CHARACTERISTICS OF STUDY PATIENTS

      Controlled clinical trials
    30. SCHOENFELD DA; FINKELSTEIN DM; RICHMAN DD
      DESIGNING PHASE-II STUDIES OF CHEMOTHERAPY FOR HIV-INFECTION USING CD4 AS AN END-POINT

      AIDS
    31. TANG DI; GELLER NL; POCOCK SJ
      ON THE DESIGN AND ANALYSIS OF RANDOMIZED CLINICAL-TRIALS WITH MULTIPLE END-POINTS

      Biometrics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 15/01/21 alle ore 20:16:57